Dzielska-Olczak M, Polakowski P
Department of Pharmacology, Medical University of Lódź, Poland.
Pol J Pharmacol. 1998 May-Jun;50(3):233-7.
The influence of 21-day administration of captopril and enalaprilat on barium chloride and adrenaline-induced experimental arrhythmias was assessed. The experiments were performed on rabbits. Arrhythmias were evoked by two alternative arrhythmogen doses. The patterns of disturbances, their frequency and duration were evaluated on the basis of ECG examination. Antiarrhythmic properties of angiotensin converting enzyme inhibitors administered for 21 days were also compared with their effects after single administration. The results were subjected to statistic analysis. On the basis of the obtained results we were able to establish that repeated administration of enalaprilat decreases the frequency of barium chloride- and adrenaline-induced arrhythmias. Repeated administration of captopril and enalaprilat shortened the duration of adrenaline- and barium chloride-induced arrhythmias. Long-term enalaprilat administration was much more effective in preventing arrhythmias than its single dose, it also proved to be more efficient than either single or repeated administration of captopril.
评估了卡托普利和依那普利拉连续给药21天对氯化钡和肾上腺素诱发的实验性心律失常的影响。实验在兔子身上进行。心律失常由两种交替的致心律失常剂量诱发。根据心电图检查评估紊乱模式、其频率和持续时间。还比较了连续给药21天的血管紧张素转换酶抑制剂的抗心律失常特性与其单次给药后的效果。结果进行了统计分析。根据所得结果,我们能够确定,依那普利拉重复给药可降低氯化钡和肾上腺素诱发的心律失常的频率。卡托普利和依那普利拉重复给药缩短了肾上腺素和氯化钡诱发的心律失常的持续时间。长期给予依那普利拉预防心律失常比单次给药有效得多,也被证明比卡托普利的单次或重复给药更有效。